Cambridge Cognition strengthens senior management team to deliver growth

/ News

Cambridge, UK – 10 April 2024: Cambridge Cognition, a leader in digital health solutions for brain health assessment, has announced the appointments of Alex Livingstone-Learmonth as Chief Commercial Officer and Annabelle Miles as Head of Marketing. These strategic additions mark a significant step as the Company continues strengthening its senior leadership team in pursuit of […]

Cambridge Cognition strengthens senior management team to deliver growth Read More »

2023 CANTAB Research Grant: The microbiota-gut-brain axis in young binge drinkers: The interplay between alcohol use, microbiota composition and neurocognitive functioning

/ Insights

We caught up with the 2023 CANTAB™ Research Grant Secondary Award Winner, Eduardo López-Caneda, from the School of Psychology at the University of Minho​who. He shares with us how the grant will help to understand cognitive training and neuromodulation as a potential strategy to modify alcohol consumption habits. I am deeply grateful to Cambridge Cognition

2023 CANTAB Research Grant: The microbiota-gut-brain axis in young binge drinkers: The interplay between alcohol use, microbiota composition and neurocognitive functioning Read More »

Cambridge Cognition announces scientific advisory board

/ News

Cambridge, UK – 21 March 2024: Cambridge Cognition, a leader in digital health solutions for brain health assessment, announces the formation of a Scientific Advisory Board (SAB). This expert board will provide scientific guidance and valuable market insights, primarily focusing on addressing emerging trends such as the integration of blood-based biomarkers and the collaborative possibilities

Cambridge Cognition announces scientific advisory board Read More »

Digital measures to advance research & quality of life in schizophrenia

/ eBooks & Whitepapers, Publications & posters

Schizophrenia spectrum disorders are complex and serious psychiatric disorders with multifaceted symptoms and associated difficulties, including psychosis, negative symptoms (e.g., loss of motivation), cognitive dysfunction, and functional impairment in major life areas. This multifaceted clinical picture in schizophrenia is also heterogeneous, both across individuals and within individuals over time, posing a challenge for studying groups

Digital measures to advance research & quality of life in schizophrenia Read More »

Prediction of mental effort derived from an automated vocal biomarker using machine learning in a large-scale remote sample

/ Publications & posters

Biomarkers of mental effort may help to identify subtle cognitive impairments in the absence of task performance deficits. Here, we aim to detect mental effort on a verbal task, using automated voice analysis and machine learning. Nick Taptiklis, Merina Su, Jennifer H. Barnett, Caroline Skirrow, Jasmin Kroll, Francesca Cormack  Audio data from the digit span

Prediction of mental effort derived from an automated vocal biomarker using machine learning in a large-scale remote sample Read More »

Digital Biomarkers & Alzheimer’s Research: Q&A with Liam Kaufman, VP of Clinical Sciences

/ Insights

Kaufman discusses the ways the digital biomarkers are improving Alzheimer’s research by directly tackling some of the unique challenges that researchers face. by Mike HollanOriginally published on PharmExec.com Researching and developing treatments for Alzheimer’s disease comes with unique challenges, due to the nature of the disease. Liam Kaufman, VP of clinical sciences at Cambridge Cognition, spoke

Digital Biomarkers & Alzheimer’s Research: Q&A with Liam Kaufman, VP of Clinical Sciences Read More »

Cambridge Cognition and ActiGraph announce partnership to accelerate central nervous system trials

/ News

by ActiGraph PENSACOLA, FL, February 20, 2024 – ActiGraph and Cambridge Cognition, leading providers of wearable digital health technologies and CNS assessments, respectively, announced a new strategic partnership to deliver a broad suite of assessments to provide a fully-rounded view of mental and physical capabilities. The companies’ technologies have been used together by top 20

Cambridge Cognition and ActiGraph announce partnership to accelerate central nervous system trials Read More »

Cambridge Cognition’s Global Teams Unite for Mental Health Causes! 

/ News

Cambridge Cognition unveils strategic partnership for Chinese market expansion Cambridge Cognition is pleased to announce an expansion in the Chinese market through a strategic partnership with Luca Healthcare Limited, a category leader in digital screening, treatment and management tools in China. Cambridge Cognition has signed an exclusive licencing agreement with Luca Healthcare

Cambridge Cognition’s Global Teams Unite for Mental Health Causes!  Read More »

Technology for successful decentralised clinical trials

/ Insights

The landscape of clinical trials is undergoing a profound transformation, one that holds the promise of faster drug development, increased patient participation, and improved data quality.  At the forefront of this revolution stands the concept of Decentralised Clinical Trials (DCTs), a game-changing approach that is reshaping the way we conduct clinical research. In this blog

Technology for successful decentralised clinical trials Read More »

Success Factors for Remote and Hybrid Decentralised Trials from Site, Technology and Service Provider Perspectives with a Focus on the RADIAL Study from Trials@Home

/ Webinars

Success Factors for Remote and Hybrid Decentralised Trials From Site, Technology and Service Provider Perspectives with a Focus on the RADIAL Study from Trials@Home About this webinar Thursday 16th November 2023 10:00-11:00 EST | 15:00-16:00 GMT Platform: Zoom Webinars Amidst the enthusiasm surrounding the advantages and efficiencies promised by Decentralised Clinical Trials (DCTs), encompassing remote

Success Factors for Remote and Hybrid Decentralised Trials from Site, Technology and Service Provider Perspectives with a Focus on the RADIAL Study from Trials@Home Read More »

Cambridge Cognition
Scroll to Top